Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients

  <div class="eh-ribbon">

      Trusted News Since 1995

    <span class="prof not-if-mobile-w820">A service for publishing professionals</span>
    <span class="not-if-mobile-w820">·</span>
    <span class="date">Friday, October 9, 2020</span>
    <span class="not-if-mobile-w430">
      ·
      <a class="article_live_counter" href="/live_feed">528,075,853</a>
      Articles
    </span>
    <span class="not-if-mobile-w550">
      ·
      3+ Million Readers
    </span>
  </div>
</header>
<footer><div class="sitemap">
    <h2 class="subheading-osc g_roboto">News Monitoring and Press Release Distribution Tools</h2>
    <div class="row-fluid">
      <div class="span3">
        <section><h3>News Topics</h3>
          </section><section><h3>Newsletters</h3>
          </section></div>
      <div class="span3">
        <section><h3>Press Releases</h3>
          </section><section><h3>Events &amp; Conferences</h3>
          </section></div>
      <div class="span3">
        <section><h3>RSS Feeds</h3>
          </section><section><h3>Other Services</h3>
          </section></div>
      <div class="span3">
        <section><h3>Questions?</h3>
          </section><br/><section/></div>
    </div>
  </div>
</footer>



<!--[if lt IE 9]>
<script src="/js/excanvas.min.js" type="text/javascript"></script>
<![endif]--><!-- Start Alexa Certify Javascript --><noscript/>
<!-- End Alexa Certify Javascript -->
<!--[if IE 7]>
<script type="text/javascript" src="/js/json2.js"></script>
<![endif]-->